Price$2.17+0.02 (+0.93%)
01:30 PM07:45 PM
News · 26 weeks101+47%
2026-01-182026-07-12
Mix7290d
- SEC Filings37(51%)
- Other24(33%)
- Earnings4(6%)
- Insider4(6%)
- Offering2(3%)
- Leadership1(1%)
Latest news
25 items- SECSEC Form DFAN14A filed by Seer Inc.DFAN14A - Seer, Inc. (0001726445) (Subject)
- PRRadoff-JEC Group Announces ISS’ Support of its Case for Change at Seer, Inc.ISS Recommends Stockholders Vote FOR Radoff-JEC Group Nominees Howard H. Berman and Luis E. Rinaldini, WITHHOLD Support on Seer Directors Terrance McGuire, Dipchand Nishar and Nicolas Roelofs and Vote AGAINST the NOL Pill Concludes That the Board’s Actions "[Raise] Questions About the Ability of the Board to Exercise Independent Oversight" of Chairman and CEO Omid Farokhzad, M.D. Radoff-JEC Group Urges Stockholders to Vote on the WHITE Proxy Card to Elect All Three of its Independent, Qualified Nominees Bradley L. Radoff and Michael Torok (together with certain of their affiliates, the "Radoff-JEC Group" or "we"), who collectively own approximately 7.7% of Seer, Inc.’s (NASDAQ:SEER) (
- SECSEC Form DEFA14A filed by Seer Inc.DEFA14A - Seer, Inc. (0001726445) (Filer)
- SECSEC Form DEFA14A filed by Seer Inc.DEFA14A - Seer, Inc. (0001726445) (Filer)
- PRSeer Board of Directors Issues Letter to Shareholders Setting the Record StraightAddressing the Radoff-JEC Group’s Misleading Claims Urges Stockholders to Vote "FOR" Seer’s Director Nominees on the BLUE Proxy Card REDWOOD CITY, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (NASDAQ:SEER) ("Seer" or the "Company") today issued a letter to stockholders containing important information for shareholders to consider in connection with the Company’s upcoming Annual Meeting of Stockholders (the "Annual Meeting") to be held on July 28, 2026. Stockholders as of May 29, 2026 will be entitled to vote at the Annual Meeting. Throughout its campaign, the Radoff-JEC Group has made many misleading claims about Seer and its performance, management, governance and value creatio
- INSIDERDirector Nishar Dipchand sold $23,265 worth of shares (10,660 units at $2.18) as part of a pre-agreed trading plan, decreasing direct ownership by 15% to 59,044 units (SEC Form 4) to cover withholding tax4 - Seer, Inc. (0001726445) (Issuer)
- SECSEC Form DFAN14A filed by Seer Inc.DFAN14A - Seer, Inc. (0001726445) (Subject)
- PRThe Radoff-JEC Group Issues Letter to Fellow Seer, Inc. Stockholders Correcting the Company’s Blatant Rewriting of HistoryEmphasizes that the Radoff-JEC Group Nominees Possess the Necessary Independence and Transaction Experience to Conduct an Objective Review of Strategic Alternatives to Benefit ALL Stockholders Reiterates the Need for Stockholders to Elect Truly Independent and Qualified Directors to Evaluate Chairman and CEO Omid Farokhzad, M.D.’s Acquisition Proposal Bradley L. Radoff and Michael Torok (together with certain of their affiliates, the "Radoff-JEC Group" or "we") today issued a letter to stockholders of Seer, Inc. (NASDAQ:SEER) ("Seer" or the "Company") ahead of the Company’s July 28, 2026 Annual Meeting of Stockholders. This press release features multimedia. View the full release here:
- SECSEC Form 144 filed by Seer Inc.144 - Seer, Inc. (0001726445) (Subject)
- SECSEC Form DEFA14A filed by Seer Inc.DEFA14A - Seer, Inc. (0001726445) (Filer)
- SECSEC Form DEFA14A filed by Seer Inc.DEFA14A - Seer, Inc. (0001726445) (Filer)
- PRSeer Board of Directors Issues Letter to Shareholders Demonstrating the Strength and Experience of Seer’s Director NomineesREDWOOD CITY, Calif., July 08, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (NASDAQ:SEER) ("Seer" or the "Company") today issued a letter to stockholders containing important information for shareholders to consider in connection with the Company’s upcoming Annual Meeting of Stockholders (the "Annual Meeting") to be held on July 28, 2026. Stockholders as of May 29, 2026 will be entitled to vote at the Annual Meeting. The Board recommends that stockholders vote "FOR" the election of Seer’s seven highly qualified nominees on the BLUE proxy card. The full text of the letter follows: Dear Fellow Seer Stockholder, At our upcoming Annual Meeting of Stockholders on July 28, 2026, your vote is critical
- SECSEC Form DEFA14A filed by Seer Inc.DEFA14A - Seer, Inc. (0001726445) (Filer)
- SECSEC Form DFAN14A filed by Seer Inc.DFAN14A - Seer, Inc. (0001726445) (Subject)
- PRThe Radoff-JEC Group Responds to Chairman and CEO Omid Farokhzad, M.D.’s Proposal to Acquire Seer, Inc.Expresses Support for Sale of Seer to Highest Bidder Emphasizes the Need for Truly Independent and Qualified Directors to Oversee Credible Strategic Review Process Urges Stockholders to vote FOR Howard H. Berman, Ph.D., Joshua S. Horowitz and Luis E. Rinaldini – Independent Candidates Who Are Committed to Overseeing a Strategic Review Process Aimed at Maximizing Value for ALL Seer Stockholders Bradley L. Radoff and Michael Torok (together with certain of their affiliates, the "Radoff-JEC Group" or "we"), who collectively own approximately 7.7% of the outstanding common stock of Seer, Inc. (NASDAQ:SEER) ("Seer" or the "Company"), today issued the following statement in response to Chai
- SECSEC Form DEFA14A filed by Seer Inc.DEFA14A - Seer, Inc. (0001726445) (Filer)
- PRSeer Files Investor Presentation Highlighting Strong Momentum, Commercial Opportunity and Significant Long-Term Value Creation PotentialSeer is Delivering Clear Progress Against its Strategic Plan and Maintaining Focus on Cost Discipline, Governance Rigor and Product Innovation Highly Qualified, Independent and Accountable Board Has Taken Decisive Action to Advance Stockholders’ Best Interests Board Urges Stockholders to Vote "FOR" ONLY Seer’s Director Nominees on the BLUE Proxy Card REDWOOD CITY, Calif., July 06, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (NASDAQ:SEER) ("Seer" or the "Company") today filed an investor presentation with the U.S. Securities and Exchange Commission in connection with its upcoming Annual Meeting of Stockholders (the "Annual Meeting") to be held on July 28, 2026. Stockholders as of May 29, 2026 w
- SECSeer Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Seer, Inc. (0001726445) (Filer)
- PRSeer Announces Receipt of Unsolicited Acquisition Proposal from Omid Farokhzad, M.D.REDWOOD CITY, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (NASDAQ:SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it has received an unsolicited, non-binding proposal from Omid Farokhzad, M.D., Seer’s Chair and Chief Executive Officer, to acquire all of the outstanding shares of Seer’s Class A common stock for $2.45 per share in cash plus two separate contingent value rights (the "Proposal"). The full text of the letter received from Farokhzad, M.D., outlining the Proposal will be included on a Form 8-K filing made by Seer. Seer’s Board of Directors will establish a Special Committee consisting solely of independent directors. Th
- PRSeer Prevails in European Patent Opposition as U.S. ITC Opens Investigation into NanomicsREDWOOD CITY, Calif., July 01, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (NASDAQ:SEER), a pioneer and trusted partner for deep, unbiased proteomic insights, today announced two significant developments that reinforce the strength of the intellectual property portfolio protecting its proprietary nanoparticle protein enrichment technology. These milestones underscore Seer's leadership in proteomics, validate the innovation behind its differentiated platform, and reflect the company's continued commitment to protecting the technologies that are advancing the future of proteomics. On June 25, 2026, the European Patent Office (EPO) concluded that European Patent No. EP4056263 will be maintained on th
- SECSEC Form DFAN14A filed by Seer Inc.DFAN14A - Seer, Inc. (0001726445) (Subject)
- PRThe Radoff-JEC Group Releases Presentation Highlighting Why Seer, Inc. Stockholders Should Vote for Boardroom ChangeDetails How Chair and CEO Omid Farokhzad, M.D., Compensation Committee Chair Terrance McGuire and Director Deep Nishar Have Burned More Than $310 Million in Cash, Adopted an Anti-Stockholder Poison Pill and Paid Themselves Excessively While Overseeing a 97% Decline in Seer’s Share Price Urges Stockholders to Elect Howard H. Berman, Ph.D., Joshua S. Horowitz and Luis E. Rinaldini to Help Prevent Further Value Destruction Bradley L. Radoff and Michael Torok (together with certain of their affiliates, the "Radoff-JEC Group" or "we"), who collectively own approximately 7.7% of the outstanding shares of Seer, Inc. (NASDAQ:SEER) ("Seer" or the "Company"), today released a presentation detaili
- SECSEC Form DFAN14A filed by Seer Inc.DFAN14A - Seer, Inc. (0001726445) (Subject)
- PRThe Radoff-JEC Group Urges Seer, Inc. Stockholders to Vote for Boardroom Change TodayBelieves New Independent Directors Are Needed to Correct the Board’s Misaligned Priorities and Prevent Further Value Destruction Reveals Seer’s Board Has Not Responded to the Radoff-JEC Group’s Stockholder-Friendly Offer Made on June 15 to Resolve the Ongoing Proxy Contest, Demonstrating the Board's Focus on its Own Entrenchment Bradley L. Radoff and Michael Torok (together with certain of their affiliates, the "Radoff-JEC Group" or "we"), who collectively own approximately 7.7% of the outstanding shares of Seer, Inc. (NASDAQ:SEER) ("Seer" or the "Company"), today issued the following statement. This press release features multimedia. View the full release here: https://www.businesswir
- PRSeer and Korea University Present Preliminary Data at ASMS 2026 Demonstrating Potential of AI-Driven Plasma Proteomics for Multi-Cancer ScreeningREDWOOD CITY, Calif., June 22, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (NASDAQ:SEER), a leader in deep, unbiased proteomics, today announced preliminary data presented at the 2026 American Society for Mass Spectrometry (ASMS) Annual Conference demonstrating the potential of the Proteograph® Product Suite to enable AI-driven approaches for multi-cancer screening. The findings were presented by Sang-Won Lee, Ph.D., Professor at Korea University and Chief Executive Officer of TargetX, and Jaewoo Kang, Ph.D., Professor at Korea University and Chief Executive Officer of AIGEN Sciences, during the Seer Breakfast Symposium on June 1 in San Diego. "By incorporating the Proteograph platform into our p
SEER FAQ
7 questionsWhat does Seer Inc. do?
Seer, Inc., a life sciences company, engages in developing and commercializing products for researchers to unlock biological information. The company develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that provides workflow to make proteomic profiling, and the analysis of the samples needed to characterize the nature of the proteome. It intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology...Where does SEER stock trade?
Seer Inc. (SEER) is listed on NASDAQ.What sector and industry is SEER in?
Seer Inc. operates in the Industrials sector, Biotechnology: Laboratory Analytical Instruments industry.When did Seer Inc. go public?
Seer Inc. (SEER) completed its IPO in 2020.What are analysts saying about SEER?
Seer Inc. has had 8 recent analyst actions on file. The most recent action was from Canaccord Genuity: Buy with a $400.00 price target on 2026-05-04.What companies are similar to SEER?
Notable peers in the same industry include A (Agilent Technologies Inc.), WAT (Waters Corporation), MTD (Mettler-Toledo International Inc.), PKI (PerkinElmer Inc.), RVTY (Revvity Inc.). Compare SEER side-by-side with any of them on Quantisnow.How can I track SEER on Quantisnow?
Quantisnow aggregates Seer Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SEER to receive live email and push alerts on every new disclosure.